Dynorphin, stress, and depression | Semantic Scholar
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Development of κ opioid receptor antagonists. | Semantic Scholar
The Role of Dynorphin and the Kappa Opioid Receptor in Schizophrenia and Major Depressive Disorder: A Translational Approach | SpringerLink
PDF) Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression?
Project 1: Therapeutic Potential of Kappa Opioid Receptor Antagonists in the Treatment of Depression (Chavkin) | Conte Center
Major Depressive Disorder and Kappa Opioid Receptor
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
Frontiers Publishing Partnerships | Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine
Opioid Agonists and Antagonists | Anesthesia Key
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
A Systematic Review on the Kappa Opioid Receptor and Its Ligands: New Directions for the Treatment of Pain, Anxiety, Depression, and Drug Abuse | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage
Major Depressive Disorder and Kappa Opioid Receptor